Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease

To evaluate the association of neighborhood socioeconomic status (SES) with time to intravenous immunoglobulin treatment, length of stay (LOS), and coronary artery aneurysms (CAAs) in patients with Kawasaki disease.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Original Article Source Type: research

Related Links:

Conclusions: Our results suggest that insufficient control of monocyte suppression and T-cell activation, especially in terms of the CD8-related immune system, are associated with IVIG resistance. The restoration of T-cell suppression may be important for KD recovery. These findings provide insight into the mechanism of IVIG resistance. PMID: 31272272 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Rheumatology - Category: Rheumatology Authors: Tags: Scand J Rheumatol Source Type: research
Source: Indian Journal of Pediatrics - Category: Pediatrics Source Type: research
Kawasaki disease (KD) is a systemic vasculitis which may be associated with coronary artery aneurysms. A notable risk factor for the development of coronary artery aneurysms is resistance to intravenous immuno...
Source: Pediatric Rheumatology - Category: Rheumatology Authors: Tags: Research article Source Type: research
The objective of this study was to determine the existence and magnitude of any increased risk of Kawasaki disease in the 28 days following PCV13 vaccination. Methods and findingsThe study population included mostly commercially insured children from birth to
Source: PLoS Medicine - Category: Internal Medicine Authors: Source Type: research
Condition:   Kawasaki Disease Interventions:   Drug: Immunoglobulin G;   Drug: Acetylsalicylic acid Sponsor:   Green Cross Corporation Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
PMID: 31261206 [PubMed - as supplied by publisher]
Source: Chinese Medical Journal - Category: General Medicine Authors: Tags: Chin Med J (Engl) Source Type: research
PMID: 31242500 [PubMed - as supplied by publisher]
Source: Pediatric Research - Category: Pediatrics Authors: Tags: Pediatr Res Source Type: research
Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, et al. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): A randomized controlled, open-label blinded endpoints, phase 3 trial. Lancet 2019;393:1128-37.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Current Best Evidence Source Type: research
Authors: Yoon KL PMID: 31208167 [PubMed - as supplied by publisher]
Source: Korean Journal of Pediatrics - Category: Pediatrics Tags: Korean J Pediatr Source Type: research
More News: Kawasaki Disease | Pediatrics